Heidbreder Christian 4
4 · Indivior Pharmaceuticals, Inc. · Filed Mar 5, 2026
Insider Transaction Report
Form 4
Heidbreder Christian
Chief Scientific Officer
Transactions
- Exercise/Conversion
Common Stock
[F1][F2]2026-03-03+101,544→ 292,306 total - Tax Payment
Common Stock
[F3]2026-03-03$31.98/sh−45,797$1,464,588→ 246,509 total - Exercise/Conversion
Performance Stock Units
[F2][F1]2026-03-03−132,565→ 0 totalExercise: $0.00From: 2026-03-03→ Common Stock (132,565 underlying)
Footnotes (3)
- [F1]Represents the vesting of performance stock units upon the determination that the performance conditions were met at 76.6% with respect to the performance stock units granted to the Reporting Person on March 3, 2023, of which 101,544 shares vested out of the 132,565 target amount.
- [F2]Each performance stock unit represents a contingent right to receive one share of the Issuer's common stock.
- [F3]Shares used to satisfy tax withholding obligations associated with the vesting of performance stock units on March 3, 2026.
Signature
/s/Alice Givens, Power of Attorney|2026-03-05